Titan Pharmaceuticals Inc (TTNP) Annual Balance Sheets

Annual · GAAP · USD millions
Access TTNP quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Titan Pharmaceuticals Inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent2.83
Cash & Short-term Investments2.00
Accounts receivable0.00
Inventories0.00
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other Current Assets0.06
Prepaid Expense And Other Assets Current0.03
Total Current Assets2.92
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Restricted Cash-
Operating Lease Right Of Use Asset-
Total Assets2.92
Liabilities
Accounts Payable, Current AC0.20
Other Accrued Liabilities, Current0.28
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.00
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities0.48
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Note Payable To Related Party-
Deferred Grant Revenue-
Operating Lease Liability Noncurrent-
Total Liabilities0.48
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock398.97
Retained Earnings / Accumulated Deficit-396.54
Other Equity0.00
Common Stockholder's Equity2.44
Preferred Stockholder's Equity0.00
Total Stockholder's Equity2.44
Liabilities & Stockholder's Equity2.92
4 historic quarters locked

Sign in to unlock the full Titan Pharmaceuticals Inc balance sheet history.

About Titan Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001829126-25-001934

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License